# Bogota Financial Corp.: overview BSBK · Nasdaq · CIK 1787414 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/bsbk.md) · [Financials](/companies/bsbk/financials.md) · [Filings](/companies/bsbk/filings.md) · [Insiders](/companies/bsbk/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [(0.03)](/filings/0001437749-25-034382.md) | not reported | [0.06](/filings/0001437749-26-016650.md) | [0.02](/filings/0001437749-26-027724.md) | [0.04](/filings/0001437749-25-034382.md) | not reported | [0.06](/filings/0001437749-26-016650.md) | [0.06](/filings/0001437749-26-027724.md) | | Free cash flow | $k | [(331) d](/filings/0001437749-25-034382.md) | [(1,094) d](/filings/0001437749-26-010056.md) | [(52.2)](/filings/0001437749-26-016650.md) | [1,920 d](/filings/0001437749-26-027724.md) | [277 d](/filings/0001437749-25-034382.md) | [988 d](/filings/0001437749-26-010056.md) | [673](/filings/0001437749-26-016650.md) | [2,146 d](/filings/0001437749-26-027724.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.54](/filings/0000950170-23-009720.md) | [0.51](/filings/0001437749-24-009812.md) | [0.05](/filings/0001437749-25-009807.md) | [(0.17)](/filings/0001437749-26-010056.md) | [0.17](/filings/0001437749-26-010056.md) | | Free cash flow | $m | [4.5](/filings/0000950170-23-009720.md) | [10.6](/filings/0001437749-24-009812.md) | [1.1](/filings/0001437749-25-009807.md) | [(3.2)](/filings/0001437749-26-010056.md) | [3.1](/filings/0001437749-26-010056.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bsbk/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $1.6m | 181,061 | | Added +9,196 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $549.5k | 60,851 | | Added +29,600 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $441.5k | 48,877 | | Reduced −1,619 | | [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $262.2k | 29,038 | | Reduced −1,737 | | [VANGUARD FIDUCIARY TRUST CO](/funds/933478.md) | 2026-06-30 | $207.1k | 22,936 | | Added +156 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $196.2k | 21,732 | | New +21,732 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $142.2k | 15,747 | | Added +3,669 | | [Cetera Investment Advisers](/funds/1666741.md) | 2026-06-30 | $135.4k | 15,000 | | Unchanged | | [NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO](/funds/1141802.md) | 2026-06-30 | $26.8k | 2,965 | | Reduced −250 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $24.1k | 2,670 | | Reduced −9 | ## Recent filings [All 222 filings](/companies/bsbk/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-13 | 16:51 ET | [10-Q](/filings/0001437749-26-027724.md) | Quarterly report, period 2026-06-30 | 0001437749-26-027724 | | 2026-07-30 | 16:15 ET | [8-K](/filings/0000943374-26-000342.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000943374-26-000342 | | 2026-07-29 | 11:00 ET | [8-K/A](/filings/0000943374-26-000332.md) | 5.07 Shareholder vote results | 0000943374-26-000332 | | 2026-06-01 | 09:12 ET | [8-K](/filings/0001193125-26-250015.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-250015 | | 2026-05-15 | 16:41 ET | [8-K](/filings/0000943374-26-000196.md) | 5.07 Shareholder vote results | 0000943374-26-000196 | | 2026-05-13 | 14:06 ET | [10-Q](/filings/0001437749-26-016650.md) | Quarterly report, period 2026-03-31 | 0001437749-26-016650 | | 2026-05-06 | 16:58 ET | [8-K](/filings/0000943374-26-000189.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000943374-26-000189 | | 2026-04-09 | 17:02 ET | [DEF 14A](/filings/0001193125-26-149819.md) | Proxy statement, period 2026-05-14 | 0001193125-26-149819 | | 2026-03-31 | 17:20 ET | [8-K](/filings/0000943374-26-000154.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000943374-26-000154 | | 2026-03-27 | 14:56 ET | [10-K](/filings/0001437749-26-010056.md) | Annual report, period 2025-12-31 | 0001437749-26-010056 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-010056.md), filed Mar 27, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1787414 - Tickers: BSBK - Exchange: Nasdaq - SIC code: 6036 Savings Institutions, Not Federally Chartered - State of incorporation: not reported - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.